Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ONO 1078

Known as: ONO-1078 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
We have recently reported the neuroprotective effect of pranlukast (ONO-1078), a cysteinyl leukotriene receptor-1 (CysLT1… Expand
Is this relevant?
2003
2003
AIM To determine whether ONO-1078 [pranlukast, 4-oxo-8-[p-(4-phenylbutyloxy)benzoyl-amono]-2-(tetrazol-5-yl)-4H-1-benzopyran… Expand
  • figure 1
  • figure 2
Is this relevant?
2002
2002
AIM To determine whether ONO-1078 (pranlukast), a potent leukotriene receptor antagonist, has neuroprotective effect on focal… Expand
  • figure 2
  • figure 1
  • figure 3
Is this relevant?
1999
1999
BACKGROUND ONO-1078 (pranlukast) is a leukotriene receptor antagonist developed in Japan. This drug has been shown to be useful… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Aerosolized cysteinyl leukotrienes (CysLTs) elicit migration of eosinophils into guinea pig lungs and the airways of patients… Expand
Is this relevant?
1994
1994
We evaluated the effect of ONO-1078, a selective leukotriene-C4, -D4, and -E4-receptor antagonist, on bronchoconstriction… Expand
Is this relevant?
1993
1993
To evaluate the involvement of sulphidopeptide leukotrienes on bronchial hyperresponsiveness in asthma, we examined the effects… Expand
Is this relevant?
1993
1993
BACKGROUND Cysteinyl leukotrienes are potent contractile agonists for airway smooth muscle. To examine the relative role of… Expand
Is this relevant?
1993
1993
Peptide leukotrienes have been suggested to play an important role in bronchial asthma. As antigen-induced bronchoconstrictions… Expand
Is this relevant?
1992
1992
We evaluated the antagonist activity of ONO-1078 against peptide leukotrienes (LTs) by a radioligand binding assay and functional… Expand
Is this relevant?